modelling immune reconstitution in paediatric bone marrow transplants london pharmacometrics...

32
Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

Upload: jemimah-williamson

Post on 16-Dec-2015

216 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

Modelling Immune reconstitution in paediatric bone marrow transplants

London Pharmacometrics Interest Group

1st March 2013

Rollo Hoare

Page 2: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

2

Contents

1. Context

2. Basic model

3. New model basis

4. The updated model

5. Final model

6. Conclusions

Page 3: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

3

Contents

1. Context

2. Basic model

3. New model basis

4. The updated model

5. Final model

6. Conclusions

Page 4: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

4

1.a) CD4 count changes with age

• CD4 Count drops with age in healthy children• Huenecke et al. [1]

Page 5: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

5

1.a) CD4 count changes with age

• This show the raw data plotted against age, with the Heunecke et al. [1] curve for healthy children

• As can be seen, this change with age is clear in the data

Page 6: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

6

1.b) Accounting for this change

Pre-adjusting for change• Log of the ratio between the

measured CD4 and the expected for a healthy child

• Square root of this ratio• Fourth root of this ratio

Building it into the model• Bi-linear model for asymptote with

age• Exponential decay model for

asymptote• Asymptote fixed as Heunecke curve• Asymptote as multiple of Heunecke

curve

• No consistency in the results• Can we know which is the correct method to model this change with age?

Page 7: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

7

Contents

1. Context

2. Basic model

3. New model basis

4. The updated model

5. Final model

6. Conclusions

Page 8: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

8

2. A more mechanistic model• Most simple is a 1 compartment turnover model:

– CD4 cells leave the thymus into a peripheral compartment– There they either proliferate or they are lost

Peripheral CD4 cells

(X)λ D

P

λ = Rate of thymic outputP = Rate of proliferationD = Rate of lossX = Concentration of CD4 cellsδ = D – P

Model has 3 parameters:λ, thymic export (cells per liter per day)δ, net loss of cells (per day)X0, initial conc. of cells (cells per litre)

Page 9: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

9

2. Issues with the basic model• Still need to find a way to account for age• Tried many models for age adjustment

– Log ratio– Square root ratio– 4th root ratio– Age adjustment of parameters themselves

• Also tried letting model chose best form of age adjustment through SCM• Still no consistency

Page 10: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

10

Contents

1. Context

2. Basic model

3. New model basis

4. The updated model

5. Final model

6. Conclusions

Page 11: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

11

3.a) A new way of applying the model• More sensible to model the total CD4 cells, rather than the CD4

concentration• λ in the model becomes thymic output in cells per day• δ the net rate of loss of cells in units of per day• We can then use information about changes to the thymus and to the body• Parameters are then more biologically relevant

Page 12: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

12

3.b) Converting concentration to total• Do this as per Bains et al. [2]• Use the WHO data from Kuczmarski et al. [3] to calculate weight for age• Then use equation from Linderkamp et al. [4] to find volume from weight

Page 13: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

13

3.c) Total body CD4 cells

• Total body CD4 against time.

Page 14: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

14

3.c) Total body CD4 cells

• Total CD4 against age, with the expected total CD4 for a health male child as found by Bains et al. [2]

Page 15: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

15

Contents

1. Context

2. Basic model

3. New model basis

4. The updated model

5. Final model

6. Conclusions

Page 16: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

16

4. The updated model• Same turnover model as before

• But functional parameters chosen such that they reflect the underlying system

• Form for thymic output chosen from Bains et al. [5]

where:

• With y(t) the proportion of cells expresing Ki67, v(t) the Heunecke et al. [1] relation for CD4 concentration with age, V(t) the blood volume with time found from the weight with time

Peripheral CD4 cells

(X)λ D

P

Page 17: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

17

4. The updated model• Form for net rate of cell loss chosen such that the form of the total CD4 with

age matches the expected total body CD4 with θλ = θδ = 1

• With y(t) defined as before. Below shows the comparison with θλ = θδ = 1.

Page 18: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

18

4. Issues with the updated model• NONMEM finds the best fit with a very low value for δ and λ, corresponding to

0.1 to 0.01 times the expected values for δ and λ. • The plots are not a good representation of the data.

Page 19: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

19

4. Issues with the updated model

• Low value for δ is caused by the slow increase in CD4 after the BMT• Low value for λ then required to keep a sensible asymptote• Two options to slow the increase in total CD4 immediately after BMT

- Decrease δ for low times, slowing the dynamics of the system- Decrease λ for low times, lowering the driving force for the increase

Page 20: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

20

Contents

1. Context

2. Basic model

3. New model basis

4. The updated model

5. Final model

6. Conclusions

Page 21: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

21

5. Thymic effects• Evidence from TREC analysis suggests that the thymus does not recover

full functionality for between 6 and 12 months after a BMT• To achieve this initial decrease in thymic function after the BMT, I used a

logistic regression on λ:

• Where θ1 and θ2 are new parameters to be estimated

• θ1 corresponds to the rate of increase of the value of λ

• θ2 corresponds to the time it takes for λ or δ to reach half its eventual value

• On λ, it causes a drop in objective function of 419.

Page 22: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

22

5. Competition effects

• Other evidence suggests that competition for homeostatic signals, such as IL-7 cytokines, may affect proliferation and loss rates for CD4 cells

• This effect on net loss can be modelled as:

• Where X is the total number of CD4 cells and θhalf is the value of X at which δ will reach half its final value.

• At the moment I fix θhalf to 60,000 cells

• This causes a further drop in objective function of 257• So the combination of the two give a drop of 676

Page 23: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

23

5. Goodness of fit plots

Page 24: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

24

5. Goodness of fit plots

Page 25: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

25

5. Visual predictive check plot

• The VPC seems to model the data well, with nearly all points for the data percentiles falling within the model prediction bands.

• The high 97.5th percentile band could be due to truncated data

Page 26: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

26

5. Model compared with expected

• A plot of the theoretical progression of a child having a BMT at age 0 days old, against the expected progression of a health child, demonstrating the early delay followed by the reconstitution in a very similar shape

Page 27: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

27

5. Final model and parameters• Final model as of today: 1 cpt turnover

θλ 0.410

θδ 0.516

X0 5780

θ1 3.56

θ2 221

Θ3 60000 (FIXED)

ηλ 3.83

ηδ 6.58

ηX0 2.42

ε 0.207

Page 28: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

28

5. Problems with the model and further work• We have two competing functions for the initial stages after the BMT• There is certain to be some inter-dependence between the parameters,

particularly between the three for the thymic and competition effects• Therefore need to be careful for this interdependence, and hence the value for

θ3 has been fixed for now

• Some work needs to be done on the competition function – there needs to be some allowance for the fact that not every patient is heading for the same asymptote due to inter-individual differences in λ and δ and fixed age effects

• Then onto multivariate analysis with Lasso and SCM

Page 29: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

29

Contents

1. Context

2. Basic model

3. New model basis

4. The updated model

5. Final model

6. Conclusions

Page 30: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

30

6. Conclusions• We now have a good model for immune reconstitution of children post BMT

that has good predictive qualities• We have found fixed effects to account for the changes in the immune system

with age• Including the effects of reduced thymic production is very important• Including the effects of competition for homeostatic signals also important• However some issues with the model still need to be sorted• We can then proceed to multivariate analysis

Page 31: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

31

Questions??

Page 32: Modelling Immune reconstitution in paediatric bone marrow transplants London Pharmacometrics Interest Group 1 st March 2013 Rollo Hoare

32

References• Huenecke et al. Eur J Haematol 2008 80 532-539• Bains et al. Blood 2009 113 (22) 5480-5487• Kuczmarski et al. Adv Data 2000 314: 1-27• Linderkamp et al. Eur J Pediatr 1977 125: 227-34 • Bains et al. J Immunol 2009 183 4329-4336